Real-World Data: Experience from the First 100 SCS Implants with Closed-Loop SCS
Part of Closed-Loop Spinal Cord Stimulation: Evoking Potentials, Hopes, and Challenges
Details
- Date
- Saturday, January 23, 2027
- Time
- 4:56 PM – 5:08 PM
- Session type
- Concurrent Session
- Schedule
- See this day
About
Neuromodulation incorporating physiologic feedback from stimulated biologic targets to adjust output has been used for a while in cardiac pacemakers and deep brain stimulators but it is a relatively new development in spinal cord stimulation (SCS). Though early research has indicated the potential for more effective stimulation with closed-loop SCS while avoiding unwanted stimulation, questions abound about effectiveness and durability of closed-loop SCS. Further, as the algorithm for closed-loop SCS was developed with low-frequency tonic stimulation, it's potential use with higher frequency SCS modes remains unclear. This session will focus on enumerating the modalities for adaptive SCS, understanding the algorithms of closed-loop SCS including evoked compound action potentials, discussing the evidence for its efficacy, and exploring its role with higher frequency modes of SCS. The speakers in this session have clinical and research experience in evaluating new modes of SCS, explaining the applicability of closed loop SCS to the audience, identifying the lacunae in evidence, and proposing areas for further research.
Presenters
-
Dr Ashish Gulve has been a Consultant in Pain Medicine at The James Cook University Hospital, Middlesbrough, United Kingdom, since 2006. He completed his specialist training in the Northeast of England and undertook a prestigious Instructor in Pain Management role at the Washington University School of Medicine in St. Louis, USA, in 2005.
Dr Gulve is the Regional Director-at-Large of the International Neuromodulation Society for Europe, Canada, and South Africa. He is the Past President of the Neuromodulation Society of the UK & Ireland and has previously served as Vice President and Treasurer of the British Pain Society.
A specialist in interventional pain management, Dr Gulve has developed particular expertise in neuromodulation, with a strong focus on clinical innovation. He has consistently been at the forefront of adopting novel neuromodulation technologies, being the first in the UK or Europe to use several cutting-edge implants.
In addition to his clinical work, Dr Gulve is actively involved in teaching, mentoring, and proctoring pain specialists across the UK and Europe. He contributes to several clinical trials in neuromodulation and has authored over 50 peer-reviewed publications. He is a sought-after speaker, having delivered numerous national and international presentations.